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P(OPh)3 (7 mol%) 
or phosphoramidite (9 mol%)
acetone, reflux, 4 h
Up to 99% yield
Up to 55% ee
(94% ee after cryst.)
Rh(acac)(C2H4)2 (3 mol%)
(R2 = Aryl, Alkenyl)
 
A general method for the catalytic 1,2-addition of aryl and alkenylboronic acids to isatins is 
described using a rhodium(I)/triphenylphosphite catalyst.1 The application of this 
transformation allows the synthesis of a variety of 3-aryl-3-hydroxyoxindole building 
blocks in high yields. As far as we know this is the first example of a rhodium-catalyzed 
arylation of ketones. An enantioselective version of this reaction using a 
rhodium/phosphoramidite system is also presented. 
 
 
Part of this chapter has been published: P. Y. Toullec, R. B. C. Jagt, J. G. de Vries, B. L. 
Feringa, A. J. Minnaard, “Rhodium-Catalyzed Addition of Arylboronic Acids to Isatins: An 
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6.1   Introduction 
Oxindoles (2-indolinones) are a class of heterocyclic compounds found in many natural 
products2 and in a number of marketed drugs.3 Of particular interest are 3-substituted  
3-hydroxyoxindoles. This substructure is encountered in a large variety of natural alkaloids 
with a wide spectrum of biological activities.4 Especially 3-alkyl-substituted  
3-hydroxyoxindoles occur frequently in nature, e.g., convolutamydines,4a,4c 
donaxaridine,4b,4c maremycins,4d dioxibrassinine,4e celogentin K,4f 3’-hydroxy-
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Figure 6.1 Natural products containing the 3-substituted 3-hydroxyoxindole moiety 
  
 






An Entry to Diversity in 3-Aryl- and 3-Alkenyl-3-hydroxyoxindoles  
Considering the frequency in which 3-hydroxyoxindoles are found in biologically active 
molecules, it is not surprising that these compounds, and derivatives thereof, constitute 
important targets in the development of drug candidates.5,6 Here, also 3-aryl-substituted  
3-hydroxyoxindoles are of particular importance. Compounds with this structural element 
also serve as important intermediates en route to indole containing alkaloids  
(e.g. diazonamide A7). Recently, chemists at Sumitomo Pharmaceuticals have reported the 
growth hormone secretagogue activity of the nonpeptidyl oxindole derivative SM-130686 
(Figure 6.2).8 Aryl-substituted 3-hydroxyoxindoles have also been identified as potent 
maxi-K9 calcium-activated potassium (KCa) channel openers.5 Maxi-K channels are thought 
to be important regulators of cellullar excitability and function and are present in many 
excitable cell types including neurons and various types of smooth muscle cells.10 
Therefore, modulators of these channels are potentially useful agents in the therapy of 
various disease states associated with both the central nervous system and smooth muscle 
tissue.11 Compound (−)-1 was identified as an effective activator of maxi-K channels. For 
both these drugs the biological activity was found to be sensitive to the pattern and nature 

















Figure 6.2 Commercial pharmacophore SM-130686 and maxi-K channel opener (−)-1 
In order to evaluate the biological activity of this type of compounds by systematic 
structural variation in a library approach it is essential that a general synthetic procedure is 
developed that makes it possible to introduce a large variety of aryl-groups, preferably in an 
enantioselective fashion. There are a number of recent reports on the catalytic 
enantioselective formation of quaternary carbon centers at the 3-position of oxindoles.12 
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not been achieved until now. Racemic 3-phenyl-3-hydroxyoxindoles have been prepared by 
cyclization of N-aryl-2-oxo-2-phenylacetamide,13 radical oxidation of oxindoles,14 or 
addition of Grignard reagents to isatins 2 (Scheme 6.1, see first transformation of route a).15 
A modification of this last method has allowed the preparation of enantiomerically enriched 
3-aryl-3-hydroxyoxindoles 3 by asymmetric hydroxylation using chiral oxaziridines 5 as 












1) NaH/ THF, 0 oC






























































Scheme 6.1 Current methodology for the preparation of enantiopure 3 
  
 






An Entry to Diversity in 3-Aryl- and 3-Alkenyl-3-hydroxyoxindoles  
The racemic 3-aryloxindole substrates 4 were prepared by dehydroxylation of the Grignard-
isatin adducts 3. Recently, Pedro et al. reported the synthesis of enantiopure 3-hydroxy-3-
phenyloxindoles via the highly diastereoselective arylation of mandelic acid 6 (route b).16 
Neither of the two current methodologies gives easy and direct access to a variety of 
substituted 3-aryl-3-hydroxyoxindoles. A more practical one-step synthesis of enantiopure 
3 would be achieved by the catalytic asymmetric addition of arylmetal reagents to isatins 2. 
However, the formation of quaternary carbon centers17 via addition of carbon nucleophiles 
to ketone derivatives still constitutes a major challenge in synthetic chemistry.18 Catalytic 
enantioselective synthesis of α-hydroxycarbonyl compounds via addition of organometallic 
nucleophiles to 1,2-dicarbonyl substrates has so far been limited to alkynylations19 and 
alkylation reactions using zinc reagents.20 Inspired by the progress in the field of rhodium-
catalyzed additions of sp2-hybridized carbon nucleophiles to a variety of electrophiles,21 
and the results described in the preceeding chapters, we decided to investigate the arylation 
and alkenylation of isatin substrates using a combination of boronic acids22,23 and rhodium 
catalysts to achieve the synthesis of 3. 
6.2   Results and Discussion 
6.2.1   The Synthesis of Racemic 3-Substituted-3-hydroxyoxindoles 
We first focused on the synthesis of racemic 3-aryl-3-hydroxyoxindoles. Experiments 
conducted with isatin 2a and 2 equiv of phenylboronic acid (8a) in the presence of a 
catalyst generated in situ from 3 mol% of Rh(acac)(C2H4)2 and 7 mol% of P(OPh)3 led to 
full conversion and 91% isolated yield of 3a after 4h at reflux temperature (Table 6.1, entry 
1). To the best of our knowledge, this is the first report of rhodium-catalyzed arylboronic 
acid addition to ketones.24 This reaction was applied to isatin substrates 2a-c and a variety 
of arylboronic acids 8a-k. As already observed by Frost for the addition of arylboronic 
acids to aldehydes,25 this 1,2-addition reaction is influenced by the electronic substitution 
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Table 6.1 Rhodium/triphenylphosphite-catalyzed 1,2-addition of aryl- and alkenylboronic 









HO R2Rh(acac)(C2H4)2 (3 mol%)
P(OPh)3  (7 mol%)
2 equiv R2B(OH)2 (8)

































entrya substrate  boronic acid product yield (%)b 
1 2a  8a 3a 91 
2 2b  8a 3b 79 
3 2c  8a 3c 99 
4 2a  8b 3d 99 
5 2a  8c 3e 99 
6 2a  8d 3f 99 
7 2a  8e 3g 98 
8 2a  8f 3h 87 
9 2a  8g 3i 66 
10 2c  8h 3j 62 
11 2a  8i 3k 43 
12 2a  8j 3l 54 
13 2a  8k 3m 96 
a All reactions were performed on a 0.2 mmol scale with 3 mol% of Rh(acac)(C2H4)2 and 7 mol% 
triphenylphosphite in acetone at reflux temperature for 4 h. b Isolated yields of 3. 
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Electron-donating groups on the isatin substrate lower the reactivity (entry 2), while 
electron-withdrawing substituents cause an increase of reactivity (entry 3). Electron-
donating substituents on the boronic acid result in high yields (entries 4-8), while electron-
withdrawing ones lead to moderate yields (entries 9-11). Steric hindrance in the boronic 
acid does not influence the yield (compare entries 4-6). Phenyl groups with m-nitro and  
p-ethoxycarbonyl electrophilic substituents, which are generally not tolerated by 
organomagnesium or organolithium reagents, were introduced here with success (entries  
9-10).24 Also o-fluorophenyl, for which the Grignard reagent is not available, was 
successfully introduced (entry 11). An additional advantage of the present strategy is the 
fact that it proceeds without protecting the amide functionality of the substrate. 
6.2.2   Enantioselective Synthesis of 3-Phenyl-3-hydroxyoxindoles 
In relation with the previous studies on asymmetric 1,2-arylations using substrates with 
carbon-heteroatom double bonds as described in Chapter 4 and 5,26 we investigated a small 
collection of phosphoramidites (Table 6.2) in the development of an enantioselective 
version of the current transformation (Scheme 6.2). Reactions were performed using the 
conditions described for the synthesis of racemic 3-phenyl-3-hydroxyoxindoles, replacing 








HO PhRh(acac)(C2H4)2 (3 mol%)
phosphoramidite L (7.5 mol%)
2 equiv PhB(OH)2 (8a)
acetone, reflux, 4 h2a 3a  
Scheme 6.2 Enantioselective addition of phenylboronic acid to isatin 
With a few exceptions, phosphoramidites are highly suitable for the rhodium-catalyzed  
1,2-addition of arylboronic acids to isatin. In general, quantitative conversions were 
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Table 6.2 Phosphoramidites studied in the rhodium-catalyzed 1,2-addition of 










































entrya ligand ee (%)b,c entrya ligand ee (%)b,c 
1 L1a 14 (S) 9 L1g 23 (S) 
2 L2a   7 (S) 10 L1h 38 (S) 
3d L3a nd 11 L2h 39 (S) 
4 L1b 11 (S) 12 L1i   4 (S) 
5 L1c 20 (S) 13 L2i 10 (S) 
6 L1d 27 (S) 14 L1j 14 (S) 
7d L1e nd  15 L2j 11 (S) 
8d L1f nd 16 L1k 33 (R) 
a All reactions were performed on a 0.2 mmol scale with 3 mol% of Rh(acac)(C2H4)2 and 7.5 mol% of 
phosphoramidite L in acetone at reflux temperature for 4 h. All reactions went to completion, except for entry 3, 7, 
and 8. b Enantiomeric excess determined by chiral HPLC. c The absolute configuration of 3a was established by 
comparison of the optical rotation with literature values (see experimental section). d Not determined: the 
conversion was too low to determine the enantioselectivity. 
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However, phosphoramidites based on primary amines, which gave rise to both high 
enantioselectivity and activity in the addition of arylboronic acids to imines (Chapter 5), 
performed unsatisfactory in the current reaction (L1e and L1f, entries 7 and 8). Although 
an explanation for this result is not evident, possibly the orientation of the substrate towards 
the rhodium-center is hindered because of hydrogen-bonding by the NH moiety of the 
ligand with functional groups in the substrate. For ligand L3a (entry 3), with a bulky 3,3’-
dimethyl-substituted BINOL-backbone, also no conversion was observed. Here, it is most 
likely that the sterics of the BINOL-backbone prevent coordination of the substrate to 
rhodium. The bidentate phosphoramidite ligand L1k, which was proven to be successful in 
the addition of arylboronic acids to aldehydes (Chapter 4), gave a promising 33% ee (entry 
16). However, the best results were obtained with ligands based on 1,2,3,4-
tetrahydroisoquinoline (entries 10 and 11). BINOL-based ligand L1h and octahydro-
BINOL based L2h showed no significant difference in enantioselectivity and provided the 
product in 38% and 39% ee, respectively. In both cases the (S)-enantiomer of the ligand 
gave the (S)-enantiomer of the product. 
Searching for the ideal reaction conditions, the effect of important parameters like the 
ligand-to-rhodium ratio, temperature, and nature of solvent were investigated using ligand 
L2h. A series of experiments was performed in which the phosphoramidite-to-rhodium 
ratio was varied between 0.5 and 6.0 (Figure 6.3). A ligand/rhodium ratio of 3/1 gave the 
optimum result. Using a lower ratio, the ee decreases slightly. This is probably due to 
competitive chelating properties of both substrate 2 and product 3. Using a higher ratio, 
enantioselectivity increases (53% ee for a ligand/rhodium ratio of 6/1). However, 
dramatically lower activity was observed. The fact that the ee increases with the 
ligand/rhodium ratio suggests that either substrate or product compete with the ligand for 
coordination to rhodium. In order to investigate this effect further, the substrate was 
gradually added to the reaction-mixture over a period of 4 h using a syringe pump. Using 
this procedure, the substrate concentration should be low during the entire course of the 
reaction and therefore competition for coordination should be reduced considerable. 
However, no change in enantioselectivity was observed in this experiment. When the 
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variation in the enantiomeric excess turned out to be negligable. This effectively rules out 
competition for coordination to rhodium between the product and the ligand, as a 
decreasing enantiomeric excess would be expected when there is more product formed. It 
was decided not to investigate this effect any further, since the difference in ee of 13% for a 
ligand/rhodium ratio of 2.5 and 6.0 represents only a small difference in transition-state 












Figure 6.3 Effects of the variation of the Rh/L2 ratio 
In order to determine the effect of the solvent upon the conversion and enantioselectivity, 
different solvents were examined at 40 oC (Table 6.3). 1,4-Dioxane (entry 3) appears to be 
the most suitable solvent for this reaction, increasing both reactivity and enantioselectivity. 
Full conversion is obtained within 2 h resulting in 55% ee. At reflux temperature the ee 
does not decrease significantly. With substrate 2a and phenylboronic acid 8a in the 
presence of a catalyst generated from 3 mol% of Rh(acac)(C2H4)2 and 9 mol% of ligand 
L2h, 3-phenyl-3-hydroxyoxindole (3a) was obtained in virtually quantitative yield and 
55% ee (Scheme 6.3).27 Upon recrystallization from 2-propanol, the supernatant gives the 
enantioenriched product in 59% yield and 94% ee. Unfortunately, when 5-methyl 
substituted (2b) and 5-chloro substituted (2c) isatins were used as substrates, under the 
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Table 6.3 Solvent variation in the rhodium-catalyzed asymmetric addition of phenylboronic 








HO PhRh(acac)(C2H4)2 (3 mol%)
(S)-L2h (9.0 mol%)
2 equiv PhB(OH)2 (8a)
solvent, reflux, 4 h2a (S)-3a  
entrya solvent  conversion (%) b ee (%)c 
1 acetone > 99 39  
2 tert-butyl methylether > 99 44  
3d 1,4-dioxane > 99 55 
4 1,2-dimethoxyethane > 99 47 
5 ethylacetate > 99 46 
6 2-propanol  80 39 
7 tetrahydrofuran > 99 45 
8 toluene > 99 53 
a Reactions were carried out on 0.2 mmol scale in 2 mL of solvent at reflux for 4 h with 2 equiv of phenylboronic 
acid in the presence of a catalyst generated from 3 mol% Rh(acac)(C2H4)2 and 9.0 mol% of phosphoramidite L2h. 
b Conversion determined by 1H-NMR. c Determined by chiral HPLC. The product could be recrystallized from  








HO PhRh(acac)(C2H4)2 (3 mol%)
(S)-L2h (9.0 mol%)
2 equiv PhB(OH)2 (8a)
1,4-dioxane, 40 oC, 2 h
3a   (R = H)   
3b   (R = Me)  
3c   (R = Cl)
R
2a  (R = H)
2b  (R = Me)













  10_Chapter_6.doc 
Chapter 6 
 
6.3   Further Developments 
Almost simultaneous with the publication of our results on this subject,28 Hayashi et al. 
reported the rhodium/MeO-MOP-catalyzed addition of aryl- and alkenylboronic acids to  
N-p-methoxybenzyl (PMB) protected isatins (Scheme 6.4) achieving excellent yields (90-









2 equiv ArB(OH)2 
KOH (15 mol%)
THF/H2O (20:1)






82-92% ee  
Scheme 6.4 Asymmetric1,2-addition of boronic acids to isatins reported by Hayashi et al.  
NH isatins underwent the addition with only moderate efficiency and a slight drop in 
enantioselectivity (49% yield and 87% ee for the addition of phenylboronic acid to 5-chloro 
isatin compared to 92% yield and 90% ee for its addition to PMB protected 5-chloro isatin). 
6.4   Conclusions 
In conclusion, we have developed a new catalyst system for the 1,2-addition of arylboronic 
acids to isatin substrates based on a combination of a rhodium(I) precursor and 2 equiv of 
triphenylphosphite. This method represents a general procedure for the formation of 3-aryl-
3-hydroxyoxindoles in good to excellent yields. Promising enantioselectivities have been 
obtained in an asymmetric version of this reaction employing a phosphoramidite ligand. 
Further studies to expand this methodology to other classes of substrates and to improve the 
enantioselection of the asymmetric addition are required. The enantioselectivity might be 
increased by screening a library of ligands, as discussed in chapter 4 and 5, varying both the 
diol and the amine part of the phosphoramidite ligands. 
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6.5   Experimental Section 
General remarks. For general information, see Chapter 2. Phosphoramidites were 
prepared according to a literature procedure.30 Spectral data for L1a, L2a, L1b, L1g, L1h, 
L2h, L1i, L2i, L1j, and L2j can be found in reference 30. Spectral data for L1c, L1k, and 
L3a can be found in reference 31. Spectral data for L1b can be found in reference 32. 
Spectral data for L1e can be found in reference 33. A procedure for the preparation of L1f, 
including spectral data, can be found in Chapter 4. 
General Procedure for Table 6.1. In a flame dried Schlenk tube flushed with nitrogen, 
1.55 mg (6.0 µmol, 3 mol%) of Rh(acac)(C2H4)2 and 3.7 µL (14.0 µmol, 7 mol%) of 
triphenylphosphite were dissolved in 2 mL of acetone. After stirring for 5 min at room 
temperature, 0.2 mmol of substrate 2 and 0.4 mmol of arylboronic acid 8 were added and 
the resulting mixture was stirred at reflux temperature. After 4 h the reaction mixture was 
cooled to RT and the solvent evaporated under reduced pressure. Products 3 were obtained 
as a solid and purified by column chromatography using eluent conditions reported for 
TLC. 
(+/-)-3-Phenyl-3-hydroxy-2-oxindole (3a). Obtained as a solid (mp 205-207 oC, dec) in 
91% isolated yield (entry 1, Table 6.1). Spectral and physical data are in 
accordance with literature.16 TLC conditions: (CH2Cl2/ethylacetate: 
80/20), Rf = 0.24. 1H NMR (DMSO-d6) δ = 10.26 (s, 1H), 7.19-7.08 (m, 
6H), 6.96 (d, J = 7.0 Hz, 1H), 6.81 (dt, J = 0.7, 7.7 Hz 1H), 6.76 (d, J = 
7.7 Hz, 1H), 6.48 (s, 1H); 13C NMR (DMSO-d6) δ = 178.44, 141.92, 141.52, 133.72, 
129.20, 128.04, 127.38, 125.39, 124.75, 122.01, 109.8, 77.28; HRMS calcd for C14H11NO2: 
m/z 225.0790, found: 225.0795; Anal. calcd for C14H11NO2: 74.6 (C), 4.93 (H), 6.22 (N), 
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(+/-)-5-Methyl-3-phenyl-3-hydroxyoxindole (3b). Obtained as a solid (mp 212-214 oC, 
dec) in 79% isolated yield (entry 2, Table 6.1). Spectral and physical 
data are in accordance with literature.16 TLC conditions: 
(CH2Cl2/ethylacetate: 80/20), Rf = 0.29. 1H NMR (DMSO-d6) δ = 
10.15 (s, 1H), 7.19-7.10 (m,  5H), 6.90 (d, J = 8.1 Hz, 1H), 6.76 (s, 
1H), 6.65 (d, J = 7.7 Hz, 1H), 6.42 (d, J = 1.5 Hz, 1H), 2.06 (s, 3H); 13C NMR (DMSO-d6) 
δ = 178.51, 141.67, 139.41, 133.86, 130.87, 129.37, 128.04, 127.31, 125.34, 125.26, 
109.58, 77.41, 20.60; HRMS calcd for C15H13NO2: m/z 239.0946, found: 239.0952; Anal. 
calcd for C15H13NO2: 75.3 (C), 5.48 (H), 5.86 (N), found: 75.0 (C), 5.65 (H), 5.56 (N).   
(+/-)-5-Chloro-3-phenyl-3-hydroxyoxindole (3c). Obtained as a solid (mp 240-242 oC, 
dec) in 99% isolated yield (entry 3, Table 6.1). TLC conditions: 
(CH2Cl2/ethylacetate: 80/20), Rf = 0.30. 1H NMR (DMSO-d6) δ = 
10.41 (s, 1H), 7.22-7.12 (m, 5H), 6.96 (d, J = 2.2 Hz, 1H), 6.78 (d, J = 
8.4 Hz, 1H), 6.64 (s, 1H), 2.52 (s, 6H); 13C NMR (DMSO-d6) δ = 
178.06, 140.80, 135.69, 130.26, 129.10, 128.22, 127.66, 125.96, 125.29, 124.68, 111.46, 
77.34; HRMS calcd for C14H10NO237Cl: m/z 259.0399, found: 259.0397. 
(+/-)-3-(4-Methylphenyl)-3-hydroxyoxindole (3d). Obtained as a solid (mp 209-211 oC, 
dec) in 99% isolated yield (entry 4, Table 6.1). TLC conditions: 
(CH2Cl2/ethylacetate: 80/20), Rf = 0.27. 1H NMR (DMSO-d6) δ = 
10.28 (s, 1H), 7.17 (dt, J = 1.1, 7.7 Hz, 1H), 7.10-7.00 (m, 4H), 6.89 
(dt, J = 1.1, 7.7 Hz, 1H), 6.82 (d, J = 7.7 Hz, 1H), 6.46 (s, 1H), 2.19 (s, 
3H); 13C NMR (DMSO-d6) δ = 178.54, 141.89, 138.58, 136.54, 133.81, 129.12, 128.57, 
125.35, 124.72, 121.96, 109.77, 77.13, 20.63; HRMS calcd for C15H13NO2: m/z 239.0946, 
found: 239.0961. 
(+/-)-3-(3,5-Dimethylphenyl)-3-hydroxyoxindole (3e). Obtained as a solid (mp 235-236 
°C, dec) in 99% isolated yield (entry 5, Table 6.1). TLC conditions: 
(CH2Cl2/ethylacetate: 80/20), Rf = 0.39. 1H NMR (DMSO-d6) δ = 
10.20 (s, 1H), 7.09 (dt, J = 1.5, 7.7 Hz, 1H), 6.93 (d, J = 7.3 Hz, 1H), 
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13C NMR (DMSO-d6) δ = 178.51, 141.89, 141.46, 136.94, 133.94, 129.10, 128.78, 124.68, 
123.01, 121.96, 109.76, 77.19, 21.04; HRMS calcd for C16H15NO2: m/z 253.11027, found: 
253.1117. 
(+/-)-3-(2-Methylphenyl)-3-hydroxyoxindole (3f). Obtained as a solid (mp 229-231 °C, 
dec) in 99% isolated yield (entry 6, Table 6.1). TLC conditions: 
(CH2Cl2/ethylacetate: 80/20), Rf = 0.33. 1H NMR (DMSO-d6) δ = 10.40 
(s, 1H), 7.73 (dt, J = 1.1, 7.7 Hz, 1H), 7.14 (t, J = 7.3 Hz, 1H), 7.10 (dt, J 
= 0.7, 7.7 Hz, 1H), 7.05 (dt, J = 1.5, 7.3 Hz, 1H), 6.90 (d, J = 7.3 Hz, 1H), 
6.77 (d, J = 7.0 Hz, 1H), 6.75 (d, J = 7.7 Hz, 1H), 6.68 (d, J = 7.0 Hz, 1H), 6.45 (s, 1H), 
1.65 (s, 3H); 13C NMR (DMSO-d6) δ = 177.74, 142.53, 139.16, 134.28, 132.31, 130.86, 
129.36, 127.42, 126.55, 125.39, 124.31, 121.96, 109.69, 76.61, 18.76; HRMS calcd for 
C15H13NO2: m/z 239.0946, found: 239.0961. 
(+/-)-3-(4-Methoxyphenyl)-3-hydroxyoxindole (3g). Obtained as a solid (mp 219-221 °C, 
dec) in 98% isolated yield (entry 7, Table 6.1). TLC conditions: 
(CH2Cl2/ethylacetate: 70/30), Rf = 0.39. 1H NMR (DMSO-d6) δ = 
10.18 (s, 1H), 7.10 (t, J = 7.7 Hz, 1H), 7.06-7.02 (m, J = 8.8 Hz, 2H), 
6.96 (d, J = 7.3 Hz, 1H), 6.32 (d, J = 7.3 Hz, 1H), 6.75-6.70 (m, 3H), 
6.37 (s, 1H), 3.57 (s, 3H); 13C NMR (DMSO-d6) δ = 178.62, 158.64, 141.86, 133.72, 
133.45, 129.11, 126.79, 124.77, 121.95, 113.44, 109.77, 76.87, 55.08; HRMS calcd for 
C15H13NO3: m/z 225.0895, found: 255.0885. 
(+/-)-3-Naphthyl-3-hydroxyoxindole (3h). Obtained as a solid (223-225 °C, dec) in 87% 
isolated yield (entry 8, Table 6.1). TLC conditions: (CH2Cl2/ 
ethylacetate: 80/20), Rf = 0.42. 1H NMR (DMSO-d6) δ = 10.34 (s, 
1H), 7.77-7.71 (m, 3H), 7.69 (d, J = 7.7 Hz, 1H), 7.37 (s, 1H), 7.35 
(d, J = 4.8 Hz, 1H), 7.18 (d, J = 9.9 Hz, 1H), 7.13 (t, J = 7.7 Hz, 
1H), 6.99 (d, J = 7.0 Hz, 1H), 6.83 (t, J = 7.7 Hz, 1H), 6.80 (d, J = 7.7 Hz, 1H), 6.64 (s, 
1H); 13C NMR (DMSO-d6) δ = 178.38, 142.01, 139.01, 133.69, 132.53, 132.30 129.35, 
127.97, 127.76, 127.41, 126.27, 126.06, 124.83, 123.88, 123.75, 122.12, 109.95, 77.45; 
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(+/-)-3-(3-Nitrophenyl)-3-hydroxyoxindole (3i). Obtained as a solid (205-208 °C, dec) in 
66% isolated yield (entry 9, Table 6.1). TLC conditions: 
(CH2Cl2/ethylacetate: 80/20), Rf = 0.47. 1H NMR (DMSO-d6) δ = 
10.52 (s, 1H), 8.13 (s, 1H), 8.10 (d, J = 7.7 Hz, 1H), 7.57 (t, J = 7.7 
Hz, 1H), 7.53 (t, J = 8.1 Hz, 1H), 7.25 (t, J = 7.7 Hz, 1H), 7.09 (d, J 
= 7.3 Hz, 1H), 6.98 (s, 1H), 6.95 (t, J = 7.3 Hz, 1H), 6.90 (d, J = 7.7 Hz, 1H); 13C NMR 
(DMSO-d6) δ = 177.48, 147.73, 143.70, 142.04, 132.52, 132.19, 129.99, 129.88, 124.88, 
122.64, 122.45, 120.12, 110.24, 76.84; HRMS calcd for C14H10N2O4: m/z 270.0640, found: 
270.0648; Anal. calcd for C14H10O4N2: 62.2 (C), 3.73 (H), 10.37 (N), found: 61.8 (C), 3.96 
(H), 9.88 (N). 
(+/-)-5-Chloro-3-(4-carbethoxyphenyl)-3-hydroxyoxindole (3j). Obtained as a solid (mp 
196-198 °C, dec) in 50% isolated yield (entry 10, Table 6.1). 
TLC conditions: (CH2Cl2/ ethylacetate: 80/20), Rf = 0.18. 1H 
NMR (DMSO-d6) δ = 10.60 (s, 1H), 7.87 (d, J = 8.4 Hz, 2H), 
7.36 (d, J = 8.8 Hz, 2H), 7.27 (ddd, J = 8.5 Hz, J = 2.2 Hz, J = 
1.1 Hz, 1H), 7.04 (d, J = 1.8 Hz, 1H), 6.92 (s, 1H), 6.88 (d, J = 8.1 Hz, 1H), 4.24 (q, J = 7.0 
Hz, 2H), 1.24 (t, J = 7.0 Hz, 3H); 13C NMR (DMSO-d6) δ = 177.53, 165.42, 145.91, 
140.84, 135.20, 129.42, 129.27, 129.20, 129.16, 125.65, 124.70, 111.68, 77.38, 60.72, 
14.17; HRMS calcd for C17H14N4O4Cl: m/z 331.0611, found: 331.0600. Anal. calcd for 
C17H14NO437Cl: 61.6 (C), 4.26 (H), 4.23 (N), found: 61.6 (C), 4.52 (H), 4.10 (N). 
(+/-)-3-(2-Fluorophenyl)-3-hydroxyoxindole (3k). Obtained as a solid (mp 200-202 °C, 
dec) in 43% isolated yield (entry 11, Table 6.1). TLC conditions: 
(CH2Cl2/ethylacetate: 80/20), Rf = 0.30. 1H NMR (DMSO-d6) δ = 10.42 
(s, 1H), 7.85 (dt, J = 1.8, 7.7 Hz, , 1H), 7.32-7.21 (m, 2H), 7.15 (dt, J = 
1.1, 7.0 Hz, 1H), 6.96 (dd, J = 9.1, 10.6 Hz, 1H), 6.85-6.79 (m, 3H), 
6.73 (s, 1H); 13C NMR (DMSO-d6) δ = 177.42, 158.41 (d, JCF = 244.7 Hz), 142.33, 132.36, 
129.51 (d, JCF = 8.5 Hz), 129.35, 128.93 (d, JCF = 13.0 Hz), 127.95 (d, JCF = 3.8 Hz), 
124.09, 121.74, 115.05 (d, JCF = 21.5 Hz), 109.66, 74.26; HRMS calcd for C14H10NO2F: 
m/z 243.0695, found: 243.0691; Anal. calcd for C14H10NO2F: 69.1 (C), 4.15 (H), 5.76 (N), 
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(+/-)-3-Thienyl-3-hydroxyoxindole (3l). Obtained as a solid (107-209 °C, dec) in 54% 
isolated yield (entry 12, Table 6.1). TLC conditions: 
(CH2Cl2/ethylacetate: 80/20), Rf = 0.24. 1H NMR (DMSO-d6) δ = 10.22 
(s, 1H), 7.32 (dd, J = 3.3, 5.1 Hz, 1H), 7.12-7.08 (m, 2H), 7.06 (dd, J = 
0.7, 2.9 Hz, 1H), 6.87 (dd, J = 0.7, 5.1 Hz, 1H), 6.84 (t, J = 7.3 Hz, 1H), 
6.73 (d, J = 8.1 Hz, 1H), 6.42 (s, 1H); 13C NMR (DMSO-d6) δ = 177.82, 142.49, 141.53, 
132.89, 129.24, 126.42, 126.21, 124.70, 122.10, 121.92, 109.82, 75.47; HRMS calcd for 
C12H9NO2S: m/z 231.0353, found: 231.0354; Anal. calcd for C12H9NO2S: 62.3 (C), 3.93 
(H), 6.06 (N), found: 62.2 (C), 4.18 (H), 5.84 (N). 
(+/-)-3-(β-Styryl)-3-hydroxyoxindole (3m). Obtained as a solid (219-221 °C, dec) in 96% 
isolated yield (entry 13, Table 6.1). TLC conditions: 
(CH2Cl2/ethylacetate: 80/20), Rf = 0.27. 1H NMR (DMSO-d6) δ = 
10.23 (s, 1H), 7.27 (d, J = 7.3 Hz, 2H), 7.17 (t, J = 7.0 Hz, 2H), 7.14-
7.07 (m, 3H), 6.87 (t, J = 7.3 Hz, 1H), 6.72 (d, J = 7.7 Hz, 1H), 6.41 
(d, J = 15.8 Hz, 1H), 6.23 (s, 1H), 6.20 (d, J = 16.1 Hz, 1H); 13C NMR (DMSO-d6) δ = 
177.78, 141.57, 135.93, 131.71, 129.36, 129.25, 129.22, 128.65, 127.82, 126.50, 124.71, 
121.87, 109.85, 76.36; HRMS calcd for C16H13NO2: m/z 251.0946, found: 251.0961. 
General procedure for the enantioselective synthesis of 3-phenyl-3-hydroxyoxindoles. 
In a flame dried Schlenk tube flushed with nitrogen, 1.55 mg (6.0 µmol, 3 mol%) of 
Rh(acac)(C2H4)2 and 8.0 mg (18.0 µmol, 9 mol%) of (S)-L were dissolved in 2 mL of  
1,4-dioxane. After stirring for 5 min at room temperature, 0.2 mmol of substrate 2 and 0.4 
mmol of phenylboronic acid (8a) were added and the resulting mixture was stirred at 40 oC. 
After 2 h the reaction mixture was cooled to RT and the solvent evaporated under reduced 
pressure. Product 3 was purified by column chromatography using eluent conditions 
reported for TLC (vide supra).  
(S)-3-Phenyl-3-hydroxyoxindole (3a). Obtained as a solid (mp 205-207 oC, dec) in 99% 
isolated yield with 55% ee. After recrystallisation from 2-propanol the supernatant gave the 
enantioenriched product in 59% isolated yield and 94% ee. The ee was determined on a 
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times: 25.5 [(S)-enantiomer] and 29.5 [(R)-enantiomer] min. [α]D = +16.5 (c = 1.06, MeOH, 
94% ee), lit. [α]D = -12.3 (c = 0.91, MeOH, (R)).16  
(S)-5-Methyl-3-phenyl-3-hydroxyoxindole (3b). Obtained as a solid (mp 212-214 oC, dec) 
in 99% isolated yield with 30% ee. The ee was determined on a Chiralcel OD-H column 
with heptane/2-propanol: 90/10, flow = 0.5 mL/min. Retention times: 23.2 [(S)-enantiomer] 
and 25.8 [(R)-enantiomer] min. The absolute configuration was deduced by analogy. 
(S)-5-Chloro-3-phenyl-3-hydroxyoxindole (3c). Obtained as a solid (mp 240-242 oC, dec) 
in 99% isolated yield with 31% ee. The ee was determined on a Chiralcel AD column with 
heptane/2-propanol: 90/10, flow = 1.0 mL/min. Retention times: 16.3 [(S)-enantiomer] and 
18.0 [(R)-enantiomer] min. The absolute configuration was deduced by analogy. 
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